Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
NateraNTRA | Open-market sale10b5-1 plan | 09/23 | 09/25 | 18,064 sh12 trades | $388.01avg. | $7,008,972.42 | −66.7% | |
Herm RosenmanDirector | NateraNTRA | Open-market sale10b5-1 plan | 06/24 | 06/26 | 16,530 sh | $250.00 | $4,132,500 | −79.5% |
Sec. and Chief Legal Officer | NateraNTRA | Open-market sale10b5-1 plan | 06/24 | 06/26 | 33,600 sh4 trades | $251.65avg. | $8,455,404.16 | −15.1% |
NateraNTRA | Open-market sale10b5-1 plan | 06/17 | 06/22 | 1,500 sh9 trades | $219.88avg. | $329,812.51 | −7.4% | |
Rowan E. ChapmanDirector | NateraNTRA | Open-market sale10b5-1 plan | 06/16 | 06/17 | 2,964 sh | $216.78 | $642,535.92 | −48.7% |
NateraNTRA | Open-market sale10b5-1 plan | 06/15 | 06/17 | 3,150 sh4 trades | $211.14avg. | $665,083.5 | −1.2% | |
NateraNTRA | Open-market sale10b5-1 plan | 06/12–06/15 | 06/16 | 100,000 sh21 trades | $214.47avg. | $21,447,298.47 | −4.2% | |
NateraNTRA | Open-market sale | 06/05 | 06/09 | 11,000 sh4 trades | $217.21avg. | $2,389,307.42 | −64.0% | |
NateraNTRA | Open-market sale10b5-1 plan | 06/04 | 06/05 | 41,124 sh14 trades | $221.03avg. | $9,089,793.78 | −27.4% | |
Director | NateraNTRA | Open-market sale | 06/01 | 06/03 | 78,000 sh6 trades | $220.31avg. | $17,184,058.65 | −6.8% |
NateraNTRA | Open-market sale10b5-1 plan | 06/01 | 06/03 | 3,000 sh4 trades | $218.43avg. | $655,294.62 | −2.1% | |
Solomon MoshkevichPresident, Clinicaldiagnostics | NateraNTRA | Open-market sale10b5-1 plan | 05/26 | 05/28 | 1,652 sh | $202.84 | $335,091.68 | −1.2% |
John FeskoPresident, Chief Bus. Officer | NateraNTRA | Open-market sale10b5-1 plan | 05/26 | 05/28 | 1,438 sh | $202.84 | $291,683.92 | −0.8% |
NateraNTRA | Open-market sale10b5-1 plan | 05/08–05/13 | 05/15 | 4,650 sh13 trades | $206.33avg. | $959,452.23 | No record | |
NateraNTRA | Open-market sale10b5-1 plan | 05/04–05/05 | 05/06 | 7,708 sh5 trades | $213.05avg. | $1,642,210.82 | −0.3% | |
CFO | NateraNTRA | Open-market sale10b5-1 plan | 05/01–05/04 | 05/05 | 795 sh2 trades | $208.79avg. | $165,984.26 | −1.4% |
Jonathan SheenaDirector | NateraNTRA | Open-market sale10b5-1 plan | 05/01 | 05/05 | 107 sh | $206.16 | $22,059.12 | −0.0% |
Steven Leonard ChapmanCEO and President | NateraNTRA | Open-market sale10b5-1 plan | 05/01 | 05/05 | 902 sh | $206.16 | $185,956.32 | −0.6% |
Daniel RabinowitzSec. and Chief Legal Officer | NateraNTRA | Open-market sale10b5-1 plan | 05/01 | 05/05 | 330 sh | $206.16 | $68,032.8 | −0.1% |
NateraNTRA | Open-market sale10b5-1 plan | 05/01 | 05/05 | 3,405 sh7 trades | $203.69avg. | $693,565.45 | −2.3% |
